IE
BLFS icon

Israel Englander’s BioLife Solutions BLFS Stock Holding History

Israel Englander’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-154,300
Closed -$3.52M – 5869
2025
Q1 		$3.52M Buy
+154,300
New +$4.06M ﹤0.01% 3215
2024
Q1 		– Sell
-30,000
Closed -$488K – 6192
2023
Q4 		$488K Buy
+30,000
New +$383K ﹤0.01% 4656

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Israel Englander's BLFS Position: Q2 2026 in Review

Israel Englander opened a new position in BioLife Solutions (BLFS) in Q2 2026: 625,658 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #1730 among its holdings. This is a return to the name: Israel Englander previously reported a position in BLFS as recently as Q3 2025.

Israel Englander first reported a position in BLFS in Q3 2017 and has held it in 34 quarters since. The position peaked at $37.6M in Q4 2023. 215 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Israel Englander held 625,658 shares of BioLife Solutions worth $17.7M as of Q2 2026.
  • BioLife Solutions was a new Israel Englander position in Q2 2026.
  • BioLife Solutions made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1730 holding.
  • Israel Englander first reported a position in BioLife Solutions in Q3 2017 and has held it in 34 quarters since.
  • Israel Englander's BioLife Solutions position peaked at $37.6M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.